Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Slatter's Fundemental of Vetrinary Ophthalmology 4th edition_Maggs, Miller, Ofri_2008

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
47.23 Mб
Скачать

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

I

NDEX

 

 

 

 

477

 

 

 

 

 

 

 

Systemic disease—cont’d

 

 

 

 

 

Tear film—cont’d

 

 

 

 

 

Toxicity—cont’d

 

 

 

 

 

 

 

 

 

 

corneal disease due to, 378t

 

 

 

 

 

 

 

precorneal

 

 

 

 

 

 

 

in ruminants, 412

 

 

 

 

 

 

 

 

 

 

endocrine, 393-395, 393f, 394f

 

 

 

 

 

 

 

 

 

anatomy and physiology of, 157-159,

 

 

 

 

 

 

 

vetch, 412

 

 

 

 

 

 

 

 

 

 

endophthalmitis/paneveitis due to, 385t

 

 

 

 

 

 

 

 

 

 

 

 

159f

 

 

 

 

 

Toxic uveitis, 214t, 222

 

 

 

 

 

 

 

 

 

 

eyelid disorders due to, 375t

 

 

 

 

 

 

 

 

 

deficiency of, 165-166

 

 

 

 

 

Toxoplasmosis, 390t, 392, 411

 

 

 

 

 

 

 

 

 

 

fungal

 

 

 

 

 

 

 

 

 

dysfunction of, 160

 

 

 

 

 

TPA. See Tissue plasminogen activator

 

 

 

 

 

 

 

 

 

 

 

 

canine and feline, 387-392, 387f, 388t-

 

 

 

 

 

 

 

of rabbit, 428

 

 

 

 

 

Traction retinal detachment, 314

 

 

 

 

 

 

 

 

 

 

 

 

 

 

390t, 391f

 

 

 

 

 

Tear film break-up time, 100

 

 

 

 

 

Transilluminator, Finoff, 86, 86f

 

 

 

 

 

 

 

 

 

 

 

 

equine, 403-404, 403f

 

 

 

 

 

Tear quantification tests in exotic pets, 427,

 

 

 

 

 

Transpalpebral enucleation-extenteration

 

 

 

 

 

 

 

 

 

 

 

 

ruminant, 411

 

 

 

 

 

 

 

 

 

 

 

 

428t

 

 

 

 

 

 

 

 

 

 

 

technique, 368-369, 368f, 369f

 

 

 

 

 

 

 

 

 

 

globe disorders due to, 385t

 

 

 

 

 

Tear replacement preparations, 56, 57t-58t,

 

 

 

 

 

Trauma, 62-66

 

 

 

 

 

 

 

 

 

 

hematologic, 396t

169-170

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

cataracts due to, 266, 266f

 

 

 

 

 

 

 

 

 

 

immune-mediated, 398-399, 399f

 

 

 

 

 

Tear-staining syndrome in dogs, 164-165, 164f,

 

 

 

 

 

 

 

causes of, 62

 

 

 

 

 

 

 

 

 

 

keratitis/keratoconjunctivitis due to, 400t

 

 

 

 

 

 

 

 

 

 

 

 

165f, 166f

 

 

 

 

 

 

 

cerebral, pupils in, 326-328, 329f, 329t

 

 

 

 

 

 

 

 

 

 

lipemia retinalis due to, 381t

 

 

 

 

 

Technique of Morgan, 154, 154f

 

 

 

 

 

 

 

consequences of, 62-66, 63f, 64f, 65f, 66f

 

 

 

 

 

 

 

 

metabolic

 

 

 

 

 

TEME. See Thromboembolic

 

 

 

 

 

 

 

eyelid, 120-121, 121f

 

 

 

 

 

 

 

 

 

 

 

 

canine and feline, 395-396, 395f

 

 

 

 

 

 

 

 

 

 

 

 

meningoencephalitis

 

 

 

 

 

 

 

 

 

third, 155, 156f

 

 

 

 

 

 

 

 

 

 

 

 

ruminant, 411-412

 

 

 

 

 

Temporalis muscle flap, 372

 

 

 

 

 

 

 

globe

 

 

 

 

 

 

 

 

 

 

neonatal, 406-408, 407f

 

 

 

 

 

Tenon’s capsule, 352, 356f

 

 

 

 

 

 

 

 

 

penetrating injuries of, 423-424

 

 

 

 

 

 

 

 

 

 

neoplastic

 

 

 

 

 

Tentorial herniation, 349

 

 

 

 

 

 

 

 

 

proptosis of, 419-421, 420f, 421f

 

 

 

 

 

 

 

 

 

 

 

 

equine, 406, 406f

 

 

 

 

 

Teratology, 30

 

 

 

 

 

 

 

lacrimal system, keratoconjunctivitis sicca

 

 

 

 

 

 

 

 

 

 

ruminant, 411, 411f

 

 

 

 

 

Tetanus, 332, 405-406

 

 

 

 

 

 

 

 

 

 

 

due to, 167

 

 

 

 

 

 

 

 

 

 

neurologic, 404-405

 

 

 

 

 

Tetracycline, 42, 165, 165f, 198

 

 

 

 

 

 

 

lens, uveitis due to, 217

 

 

 

 

 

 

 

 

 

 

neuromuscular, 405-406

 

 

 

 

 

TFBUT. See Tear film break-up time

 

 

 

 

 

 

 

in optic radiation and visual cortex

 

 

 

 

 

 

 

 

 

 

neuroophthalmic disorders due to, 403t

 

 

 

 

 

Thelazia spp., 146t

 

 

 

 

 

 

 

 

 

 

 

disorders, 349

 

 

 

 

 

 

 

 

 

 

optic nerve disease due to, 384t, 402t

 

 

 

 

 

Therapeutic formations, 33

 

 

 

 

 

 

 

orbital, 362t

 

 

 

 

 

 

 

 

 

 

orbital disorders due to, 404t

 

 

 

 

 

Therapeutic soft contact lenses, 59

 

 

 

 

 

 

 

in raptors and pet birds, 435-436, 435f

 

 

 

 

 

 

 

 

 

 

parasitic, 390t, 392-393

 

 

 

 

 

Thiamine deficiency, 349

 

 

 

 

 

 

 

scleral, 200, 201f

 

 

 

 

 

 

 

 

 

 

protozoal

 

 

 

 

 

Third eyelid, 151-156

 

 

 

 

 

 

 

uveal, 214t, 222-223

 

 

 

 

 

 

 

 

 

 

 

 

equine, 402-403

 

 

 

 

 

 

 

anatomy and physiology of, 151, 152f

 

 

 

 

 

Treponema cuniculi, 429, 429f

 

 

 

 

 

 

 

 

 

 

 

 

ruminant, 411

 

 

 

 

 

 

 

disease of, 152-154, 153f, 154f, 323

 

 

 

 

 

Triamcinolone, 47, 215, 221

 

 

 

 

 

 

 

 

 

 

pupillary disorders due to, 402t

 

 

 

 

 

 

 

embryonic and fetal development of, 28-29,

 

 

 

 

 

Trichiasis, 113, 114f, 115, 115f

 

 

 

 

 

 

 

 

 

 

retinal/chorioretinal scarring and atrophy

 

 

 

 

 

 

 

 

 

 

 

 

30f

 

 

 

 

 

Trichromacy, 8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

due to, 381t

 

 

 

 

 

 

 

examination of, 87, 151-152

 

 

 

 

 

Trichromatic vision, 290

 

 

 

 

 

 

 

 

 

 

retinal detachment due to, 383t, 402t

 

 

 

 

 

 

 

gland of, 157, 158f

 

 

 

 

 

Trifluorothymidine, 45

 

 

 

 

 

 

 

 

 

 

retinal hemorrhage due to, 382t, 402t

 

 

 

 

 

 

 

inflammatory disorders of, 155

 

 

 

 

 

Trifluridine, 45, 45t, 145-146

 

 

 

 

 

 

 

 

 

 

scleral and episcleral disease due to, 379t

 

 

 

 

 

 

 

neoplasm of, 154-155, 154f, 155f, 156f

 

 

 

 

 

Trigeminal nerve

 

 

 

 

 

 

 

 

 

 

toxic, 412

 

 

 

 

 

 

 

prominence of, 151-152

 

 

 

 

 

 

 

anatomy and function of, 14, 16f, 318

 

 

 

 

 

 

 

 

 

 

uveitis due to, 379t

 

 

 

 

 

 

 

protrusion of, 332-333, 332f

 

 

 

 

 

 

 

dysfunction of, 335

 

 

 

 

 

 

 

 

 

 

 

 

anterior, 401t

 

 

 

 

 

 

 

trauma to, 155, 156f

 

 

 

 

 

 

 

testing of, 100

 

 

 

 

 

 

 

 

 

 

 

 

posterior, 380t, 401t

 

 

 

 

 

Third eyelid flap for corneal ulcers, 188-189

 

 

 

 

 

Trochlear nerve

 

 

 

 

 

 

 

 

 

 

viral

 

 

 

 

 

360-degree conjunctival grafts, 187, 187f, 188

 

 

 

 

 

 

 

anatomy and function of, 14, 318

 

 

 

 

 

 

 

 

 

 

 

 

canine, 374-376, 375f, 377f

 

 

 

 

 

Thrombocytopenia, 396, 396t

 

 

 

 

 

 

 

strabismus due to lesions of, 332, 332f

 

 

 

 

 

 

 

 

 

 

 

 

equine, 399-400

 

 

 

 

 

Thromboembolic meningoencephalitis, 349,

 

 

 

 

 

 

 

testing of, 100

 

 

 

 

 

 

 

 

 

 

 

 

feline, 376-382, 377f, 379f, 381f, 382f

 

 

 

 

 

 

 

 

 

 

 

 

409, 409f

 

 

 

 

 

Tropicamide, 53, 53b

 

 

 

 

 

 

 

 

 

 

 

 

ruminant, 409-411, 410f

 

 

 

 

 

Thrombopathy, 396

 

 

 

 

 

TSCLs. See Therapeutic soft contact lenses

 

 

 

 

 

 

 

 

Systemic drug administration, 34f, 36-37

 

 

 

 

 

Ticarcillin, 185b

 

 

 

 

 

Tuberculosis, 390t, 409

 

 

 

 

 

 

 

 

Systemic lupus erythematosus, eyelid skin

 

 

 

 

 

Ticks, eyelid, 128t

 

 

 

 

 

Tumor. See Neoplasm

 

 

 

 

 

 

 

 

 

 

 

 

 

 

disease due to, 131t

 

 

 

 

 

Tissue adhesives, 56, 189

 

 

 

 

 

Tunica vasculosa lentis, 20, 27, 28f

 

 

 

 

 

 

 

 

Systolic blood pressure, normal, 397t

 

 

 

 

 

Tissue plasminogen activator, 56, 280

 

 

 

 

 

 

 

persistent, 279

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tissue scaffolding in wound healing, 75-76

 

 

 

 

 

Turtles, 436-438

 

 

 

 

 

 

 

 

T

 

 

 

 

 

Tobramycin, 42, 185, 185b

 

 

 

 

 

TVL. See Tunica vasculosa lentis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

“Tacking” for entropion, 117, 117f

 

 

 

 

 

Tonography, 97

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tacrolimus, 50, 169, 170

 

 

 

 

 

Tonometry, 95-97, 95f, 96f, 97f, 232

 

 

 

 

 

U

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tapetum

 

 

 

 

 

Tono-Pen, 96-97, 96f

 

 

 

 

 

Uberreiter’s syndrome, 194

 

 

 

 

 

 

 

 

 

 

anatomy of, 1, 206, 207, 208f, 295-297,

 

 

 

 

 

Tono-Vet rebound tonometer, 97, 97f

 

 

 

 

 

Ulcer, corneal. See Corneal ulceration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

295f, 296f, 297f

 

 

 

 

 

Topical anesthetics

 

 

 

 

 

Ultrafiltration, aqueous, 230

 

 

 

 

 

 

 

 

 

 

examination of, 90-91, 92-93, 92f

 

 

 

 

 

 

 

for injections, 36

 

 

 

 

 

Ultrasonography, 103-104, 103f, 104f

 

 

 

 

 

 

 

 

 

 

function of, 285, 287f

 

 

 

 

 

 

 

for microbiologic samplings, 83-84

 

 

 

 

 

Uvea, 203-229

 

 

 

 

 

 

 

 

 

 

hyperreflectivity of, retinopathies and, 307

 

 

 

 

 

Topical application of drugs, 33, 34f

 

 

 

 

 

 

 

anatomy and physiology of, 203-208, 204f

 

 

 

 

 

 

Tarsal gland, 107, 108f

 

 

 

 

 

Tortoises, 436-438

 

 

 

 

 

 

 

 

 

in blood-ocular barrier, 207-208, 208f

 

 

 

 

 

 

Tarsorrhaphy, temporary, for corneal ulcers,

 

 

 

 

 

Toxicity

 

 

 

 

 

 

 

 

 

choroid in, 206-207, 207f, 208f

 

 

 

 

 

 

 

 

 

 

 

 

 

 

188-189, 188f

 

 

 

 

 

 

 

cataracts due to, 267

 

 

 

 

 

 

 

 

 

ciliary body in, 203-206, 205f, 206f,

 

 

 

 

 

 

T cells

 

 

 

 

 

 

 

cerebral disturbances due to, 349

 

 

 

 

 

 

 

 

 

 

 

207f

 

 

 

 

 

 

 

 

 

 

cyclosporine and, 48-49

 

 

 

 

 

 

 

enrofloxacin, 42-43

 

 

 

 

 

 

 

 

 

iris in, 203, 204f, 205f

 

 

 

 

 

 

 

 

 

 

in immune-mediated disease, 71

 

 

 

 

 

 

 

locoweed, 167, 412

 

 

 

 

 

 

 

congenital abnormalities of, 209-211, 209f,

 

 

 

 

 

 

Tear film

 

 

 

 

 

 

 

oxygen, 313-314

 

 

 

 

 

 

 

 

 

 

 

210f, 211f, 211t

 

 

 

 

 

 

 

 

 

 

conjunctiva and, 135

 

 

 

 

 

 

 

retinopathy due to, 313-314, 313f

 

 

 

 

 

 

 

cysts of, 224-225, 224f

 

 

 

 

 

 

 

 

478 INDEX

Uvea—cont’d

Veratrum californium, 31, 32f

Vitreous—cont’d

glaucoma secondary to, 250b, 253

Vertebral sinuses, 13

degeneration of, 280

hyphema, 223-224, 224f

Vestibular system, 339-342, 340f

retinal detachment and, 315

immune mechanisms and, 209

disorders of, 341-342

elongation of, 279

iris atrophy in, 227-228, 228f

eye position in, 341

embryonic and fetal development of, 24, 26f

iris hypoplasia in, 227

strabismus due to, 331

examination of, 93-94

neoplasm of, 225-227, 225b, 225f, 226f,

nystagmus and, 339-341, 340b

hemorrhage of, 280, 280f

227f

Vestibuloocular reflex, 17t

hyalocentesis of, 282-283, 283f, 283t

pathologic reactions in, 208-209

Vetch toxicity, 412

infection and inflammation of, 280-281

surgical procedures on, 228

Vidarabine, 45, 45t, 146

lens luxation and, 273, 282

Uveitis, 208, 211-222

Viral infection

mass in, 282, 282f

anterior (See Anterior uveitis)

canine, 374-376, 375f, 377f

opacities of, 281

associated with neoplasia, 78-79

conjunctival, 143-146, 144b, 144f, 145t

pathologic reactions in, 278-279

cataract and, 263-264, 269

in birds, 436

persistent hyperplastic primary, 279-280,

clinical signs of, 211-212, 212f

in rabbits, 430

280f

diagnosis of, 213-215, 213t, 214t, 215t

equine, 399-400

cataracts and, 265-266

immune-mediated, 216-222

in encephalitis, 404-405

replacement of, 283-284

dental disease and, 217

of eyelid skin, 130t

retinal detachment and, 282

due to Dirofilaria immitis, 222

feline, 376-382, 377f, 379f, 381f, 382f

surgical removal of portion of, 282-283,

equine recurrent, 217-222, 218f, 219f,

ruminant, 409-411, 410f

283f, 283t

220f, 221f

uveal, 214t

synchysis scintillans of, 281-282, 281f

feline, 217

Viral papillomatosis of eyelid, 126, 126f

syneresis of, 273, 273f, 278

lens-induced, 216-217, 217f

Vision, 1-8

Vogt-Koyanagi-Harada–like syndrome, 72,

phacoclastic in rabbits, 222, 222f

assessment of, 318-320, 320f, 321f

132t, 216, 398-399, 399f

pigmentary in golden retrievers, 217

behavioral testing of, 101-102

von Willebrand’s disease, 396t

toxic, 222

color, 7-8, 8f, 9f

Voriconazole, 43, 44t, 192t

uveodermatologic syndrome, 216

deficits of

V-to-Y blepharoplasty, 120, 120f

infectious, 216

clinical signs of, 323t

 

phacoclastic, 264

in glaucoma, 238, 238f

W

 

inflammatory exudate in, 72, 72f

lesions in, 323-328

Waardenburg’s syndrome, 211

phacolytic, 263-264

depth perception and, 4, 5f

Wall eye, 211

posterior

dichromatic, 291

Wanderers, 407

defined, 69

field of view and, 3-4, 3f, 4f

Watch eye, 211

systemic causes of, 380t, 401t

flickering light sensitivity and, 2-3

Wedge resection

in rabbits, 431

light sensitivity and, 1-2, 2f, 3f

for ectropion, 120

sequelae of, 212-213

loss of in retinopathies, 306-307, 307f

for entropion, 117

serous, 79

motion sensitivity and, 2

for eyelid coloboma, 109, 112f

systemic causes of, 379t

postoperative, cataract surgery, 270-271

Wharton-Jones blepharoplasty, 120, 120f

traumatic, 222-223

scotopic, 289

White blood cells, corneal stromal infiltration

treatment of, 215-216

trichromatic, 290

with, 180, 180f

Uveodermatologic syndrome, 72, 132t, 216,

visual acuity and, 4-7, 5f, 6f, 7f

White petroleum ointment, 58t

398-399, 399f

Visual acuity, 4-7, 5f, 6f, 7f

Wolves, visual streak of, 6-7, 7f

 

Visual axis, 352, 353f

Wound healing, 73-77

V

Visual cortex

conjunctival, 135

 

Vaccine

anatomy of, 10

corneal, 176-178, 177f

for equine recurrent uveitis, 221-222

disease of, 348-349

diseases resulting from defective, 76-77

ischemic dermatopathy induced by, 132t

Visual evoked potentials, 102, 102f, 322

germinal cells in, 74-75, 74f, 75f

Valacyclovir, 45, 146

Visual field, 3-4, 3f, 4f

nutrition in, 76

Vancomycin, 185b

central visual pathway and, 9

tissue scaffolding in, 75-76

Vascularization

Visual pathways, central, structure and function

 

corneal, 179, 179f

of, 8-10, 10f, 11f

X

 

vitreous, 279

Visual streak, visual acuity and, 6-7, 7f

X-irradiation, 59-60

Vascular system

Vitamins, 59

 

anatomy of

Vitamin A deficiency, 292, 312, 312b, 313f, 350

Y

 

arterial supply in, 10-12, 12f

Vitamin B1 deficiency, 349

Yeasts in uveitis, 214t

venous drainage in, 12-13, 13f

Vitiligo, 133t

 

disease of, eyelid skin, 132t

Vitrectomy, 283, 283f

Z

 

embryonic and fetal development of, 26-27,

Vitreoretinal surgery, advanced, 284

Zinc-responsiveness dermatitis, 132t

28f

Vitreoretinopathy, proliferative, 278-279

Zonal fibers of ciliary body, 203, 206f

hyaloid, 20

Vitreous, 277-284

Zygomatic mucocele, 363

retinal, 287, 288t, 290f, 292f

anatomy and physiology of, 277-278, 278f

Zygomatic salivary gland

Vasoactive agents, 141

aqueous humor misdirection syndrome of, 282

in ferret, 432

Venography, orbital, 103, 358-359, 359f

asteroid hyalosis of, 281-282, 281f

relationship to orbit, 352, 356f

Venous drainage, 12-13, 13f

congenital and developmental abnormalities

Zygomatic sialogram, contrast, 103

Venous plexus, orbital, 13, 13f

of, 279-280, 280f

 

Соседние файлы в папке Английские материалы